Varenicline Tablet
Product Images NDC 60290-077

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 60290-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Umedica Laboratories Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Varenicline Tablets Blister 0pt5mg)

Image Description (Varenicline Tablets Blister 0pt5mg)
This is a product label for Varenicline tablets manufactured by Umedica Laboratories Pvt. Ltd. in India. The tablets are 0.5mg each and the batch was produced under manufacturing license number G/25/491. The revision date is 02/24, and the National Drug Code (NDC) is 60290-077-02. The lot number and expiration date are provided for quality control and inventory purposes.*
FDA Label Image

Image Description (Varenicline Tablets Blister 1mg)

Image Description (Varenicline Tablets Blister 1mg)
FDA Label Image

Image Description (Varenicline Tablets Carton 0pt5mg)

Image Description (Varenicline Tablets Carton 0pt5mg)
This is a description of a medication called Varenicline in tablet form. It is dispensed with a Medication Guide to each patient. The medication is available in a package of 60 unit-dose tablets. The tablets contain 0.5 mg of varenicline free base. The storage instructions suggest keeping the tablets between 20°C to 26°C, with temperature excursions permitted between 15°C to 30°C. The manufacturing information indicates that the tablets are made in India by Umedica Laboratories Pvt. Ltd.*
FDA Label Image

Image Description (Varenicline Tablets Carton 1mg)

Image Description (Varenicline Tablets Carton 1mg)
This is a description of Varenicline tablets, each unit-dose containing 1mg of the active ingredient. The tablets are meant to be taken in the morning and evening. It is recommended to dispense the Medication Guide to each patient. The tablets are produced by Umedica Laboratories in Vapi, Gujarat, India. The text includes dosage instructions and storage information.*
FDA Label Image

Image Description (Varenicline Tablets Fig 1)

Image Description (Varenicline Tablets Fig 1)
FDA Label Image

Image Description (Varenicline Tablets Fig 2)

Image Description (Varenicline Tablets Fig 2)
FDA Label Image

Image Description (Varenicline Tablets Fig 3)

Image Description (Varenicline Tablets Fig 3)
This text seems to be a chart showing the comparison between Varenicline 1.0 mg BID and Placebo in terms of continuous abstinence over a period of 48 weeks. The numbers represent different time points during the study.*
FDA Label Image

Image Description (Varenicline Tablets Label 0pt5mg)

Image Description (Varenicline Tablets Label 0pt5mg)
This description revolves around a medication called Varenicline, which is manufactured by Umedica Laboratories Pvt. Ltd. in India. Each tablet contains 0.85 mg of varenicline tartrate, equivalent to 0.5 mg of varenicline free base. The tablets are meant to be stored at a controlled room temperature of 15-30°C (59-66°F). The dosage and use instructions, along with the expiration date, are available in the accompanying prescribing information. The medication guide for Varenicline can be accessed on the website provided or by calling the given number. It is advised to dispense the tablets in light-resistant, child-resistant containers.*
FDA Label Image

Image Description (Varenicline Tablets Label 1mg)

Image Description (Varenicline Tablets Label 1mg)
This text provides information about a medication called Varenicline in tablet form. Each tablet contains 1.71g of varenicline tartrate, equivalent to 1g of varenicline free base. The storage conditions are specified as between 25°C to 2019 68°F and below 15° to 25°C 59° to 86°F. It mentions dispensing in tight, child-resistant containers at controlled room temperature. For dosage and usage instructions, one needs to refer to the accompanying prescribing information and medication guide available online or via phone. The NDC number is given as 60290-078-01. The manufacturing details indicate that the tablets are manufactured by Umedica Laboratories Pvt. Ltd. in India with a manufacturing license number - G/25/491.*
FDA Label Image

Image Description (Varenicline Tablets Structure)

Image Description (Varenicline Tablets Structure)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.